high discontinuation rate of natalizumab in jc virus seropositive patients due to significant anxiety and safety feelings

R. Alroughani

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Funding Agency

@article{e84107380323489eb2a714df7547debd,

title = "high discontinuation rate of natalizumab in jc virus seropositive patients due to significant anxiety and safety feelings",

author = "R. Alroughani",

year = "2014",

doi = "10.1177/1352458514526945",

language = "American English",

volume = "20",

pages = "1667--1668",

journal = "Multiple Sclerosis Journal",

issn = "1352-4585",

publisher = "SAGE Publications Ltd",

number = "12",

}

TY - JOUR

T1 - high discontinuation rate of natalizumab in jc virus seropositive patients due to significant anxiety and safety feelings

AU - Alroughani, R.

PY - 2014

Y1 - 2014

U2 - 10.1177/1352458514526945

DO - 10.1177/1352458514526945

M3 - Article

SN - 1352-4585

VL - 20

SP - 1667

EP - 1668

JO - Multiple Sclerosis Journal

JF - Multiple Sclerosis Journal

IS - 12

ER -